36 Stocks Moving In Tuesday's Mid-Day Session



  • China SXT Pharmaceuticals, Inc. SXTC jumped 88.1% to $0.38 after declining 9% on Monday.
  • IGM Biosciences, Inc. IGMS shares jumped 49.8% to $22.46. Sanofi SA SNY and IGM Biosciences signed an exclusive worldwide collaboration agreement for IgM antibodies agonists against three oncology targets and three immunology/inflammation targets.
  • The Lovesac Company LOVE shares jumped 31% to $61.76. Lovesac reported fourth-quarter FY22 sales growth of 51.3% year-on-year, to $196.2 million, beating the consensus of $174.33 million.
  • Randolph Bancorp, Inc. RNDB gained 25.6% to $26.50 after Hometown Financial Group announced plans to acquire Randolph Bancorp for $27 per share in cash.
  • Gelesis Holdings, Inc. GLS gained 23.7% to $6.02. Gelesis Holdings recently reported FY EPS of $85.22.
  • Guardforce AI Co., Limited GFAI rose 23.2% to $1.4550 after the company announced it is in the process of establishing subsidiaries in Dubai and Australia, with a focus on Robotics as a Service rollout initiatives.
  • Robinhood Markets, Inc. HOOD gained 23.2% to $15.86. Robinhood Markets on Tuesday unveiled extended trading hours for its brokerage platform, building on the company's aim to make investing more accessible for all.
  • TRxADE HEALTH, Inc. MEDS rose 22.4% to $2.8050 after the company reported Q4 earnings results.
  • Nielsen Holdings plc NLSN jumped 20.8% to $26.83 after the company announced it will be acquire by a private equity consortium led by Evergreen Coast Capital and Brookfield Business Partners for $28 per share.
  • MicroVision, Inc. MVIS gained 20.1% to $5.02. Microvision was granted US patent 'Alteration of resonant mode frequency response in mechanically resonant device.'
  • Grid Dynamics Holdings, Inc. GDYN gained 15.6% to $13.67.
  • Molecular Templates, Inc. MTEM jumped 14.8% to $3.10 as the company posted a narrower quarterly loss.
  • Ginkgo Bioworks Holdings, Inc. DNA gained 14.7% to $4.29 after the company reported better-than-expected Q4 sales results and issued FY22 sales guidance above analyst estimates.
  • Dave Inc. DAVE jumped 14.3% to $7.45.
  • NexImmune, Inc. NEXI rose 11.1% to $3.5990 after declining 24% on Monday.
  • Hycroft Mining Holding Corporation HYMC shares rose 10.8% to $2.57 after jumping 80% on Monday.
  • Nautilus, Inc. NLS gained 10.4% to $4.40.
  • ReShape Lifesciences Inc. RSLS rose 9.6% to $1.48 after reporting a surge in FY21 sales.


  • NeoGenomics, Inc. NEO shares dipped 36.5% to $11.30 after the company announced it expects Q1 sales to be below its previously issued guidance range and withdrew its FY22 guidance. The company also announced Mark Mallon has agreed to step down as CEO.
  • Aveanna Healthcare Holdings Inc. AVAH fell 26% to $3.99 after the company said FY21 EPS results were down from last year. The company also issued FY22 sales guidance below analyst estimates. B of A Securities downgraded the stock from Buy to Neutral and lowered the price target from $10 to $5.5.
  • Progenity, Inc. PROG fell 25.2% to $1.2050 after reporting Q4 results.
  • Soleno Therapeutics, Inc. SLNO fell 23.6% to $0.2197 after the company announced pricing of a roughly $15 million underwritten public offering.
  • Marin Software Incorporated MRIN fell 18.4% to $2.9950 after jumping over 35% on Monday.
  • Stryve Foods, Inc. SNAX shares fell 17.9% to $1.6376 after reporting weak quarterly sales.
  • SCYNEXIS, Inc. SCYX dipped 17.7% to $3.87 following Q4 results.
  • Creative Medical Technology Holdings, Inc. CELZ dropped 17.6% to $3.74.
  • Lipocine Inc. LPCN shares fell 16.2% to $1.5250. Antares Pharma announced the FDA granted final approval for oral testosterone replacement therapy Tlando for conditions associated with a deficiency or absence of endogenous testosterone, or hypogonadism in adult males. Tlando was developed by Lipocine, with the company exclusively out-licensing the U.S. commercialization rights to Antares.
  • Ocuphire Pharma, Inc. OCUP fell 14.8% to $3.6191 after the company reported topline results from MIRA-3 Phase 3 FDA registration trial for Nyxol® in the reversal of mydriasis.
  • Tellurian Inc. TELL dropped 14.7% to $4.63.
  • Benson Hill, Inc. BHIL fell 14.2% to $3.43. Barclays maintained Benson Hill BHIL with an Overweight and lowered the price target from $10 to $8.
  • Kaixin Auto Holdings KXIN fell 13% to $1.27. Kaixin shares jumped over 31% on Monday after the company announced an order for 20,000 electric vehicles.
  • Save Foods, Inc. SVFD dropped 12.6% to $5.36.
  • Terran Orbital Corporation LLAP fell 12.6% to $10.31.
  • Revelation Biosciences, Inc. REVB dipped 12.2% to $2.07.
  • Sky Harbour Group Corporation SKYH dropped 10.1% to $18.89.
  • Conn's, Inc. CONN fell 7.1% to $18.97 following Q4 results.
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers